Comparison of efficacy and safety of mirabegron and vibegron in the treatment of Overactive Bladder (OAB) in older women: A systematic review and meta-analysis. [PDF]
PLoS OneZhang J +5 more
europepmc +1 more source
Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis. [PDF]
Rev Bras Ginecol Obstet, 2023 Sartori LGF +6 more
europepmc +1 more source
Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-neurogenic Overactive Bladder in Children: A Randomized Controlled Trial. [PDF]
Int Braz J UrolMansour I +4 more
europepmc +1 more source
Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. [PDF]
PLoS One, 2023 Yamamoto S +4 more
europepmc +1 more source
Evaluating the safety and effectiveness of α-blockers versus mirabegron for medical expulsive therapy in ureteral calculi: A Systematic review and meta-analysis. [PDF]
PLoS OneYan H +5 more
europepmc +1 more source
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek<sup>®</sup> in adult patients with overactive bladder. [PDF]
Investig Clin UrolPark JS +4 more
europepmc +1 more source
Enantioseparation of Mirabegron Using Cyclodextrin-based Chiral Columns: High-performance Liquid Chromatography and Molecular Modeling Study. [PDF]
J Sep SciMhammad A +5 more
europepmc +1 more source
Enantioselective Activity and Toxicity of Chiral Herbicides [PDF]
, 2011 Mengling Tang, Weiping Liu
core +1 more source
Is the Addition of CO<sub>2</sub> Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. [PDF]
Medicina (Kaunas)Kypriotis K +8 more
europepmc +1 more source